MAPT and Alzheimer disease: In accordance with these findings, the phosphatidylserine signal showed a significant increase in early disease stages and Bayesian inference showed a higher chance for the presence of this signal in AT8 + tau-containing synaptosomes, even in non-AD brain samples and in late-stage AD, where the fraction of synaptosomes containing phosphatidylserine was reduced.